Established in 2020 Wednesday, March 27, 2024


UVA discovery reveals potential way to prevent heart attacks, strokes
New research from the lab of UVA researcher Gary K. Owens reveals surprising new information about the makeup of the protective caps our bodies build over these lesions, and about the factors that determine their stability.



CHARLOTTESVILLE, VA.- Scientists at the University of Virginia School of Medicine have identified a potential way to head off heart attacks and strokes by strengthening the fibrous caps overlying atherosclerotic plaques that naturally accumulate inside our arteries. These fatty lesions can rupture, triggering blood clots that cause disability or death.

New research from the lab of UVA researcher Gary K. Owens reveals surprising new information about the makeup of the protective caps our bodies build over these lesions, and about the factors that determine their stability. The study supports recent findings that certain types of inflammation might actually help stabilize plaques. Doctors may one day be able to use these insights to strengthen the caps and prevent the plaques from rupturing.

“These studies redefine our understanding of both how the caps form and what makes them strong,” said Owens, the head of UVA’s Robert M. Berne Cardiovascular Research Center and a member of UVA’s departments of Molecular Physiology and Biological Physics and of Internal Medicine (Division of Cardiology). “These studies were completed by a large team of highly talented investigators from UVA and abroad but led by three outstanding trainees from my laboratory, including co-first authors Alexandra Newman, Vlad Serbulea and Dr. Richard Baylis.”

Understanding atherosclerotic plaques
Unstable atherosclerotic plaques account for the majority of heart attacks and a large fraction of strokes, making these lesions the leading cause of death worldwide. The protective caps our bodies create over these lesions act like a patch on a tire, preventing them from rupturing and triggering catastrophic blood clot formation, which, in blood vessels supplying the heart or brain, can cause a heart attack or stroke. Therefore, improving our understanding of how the cap forms is of major clinical importance. “Despite decades of research, little is known regarding the factors and mechanisms that promote formation and maintenance of a stable fibrous cap,” the UVA researchers write in a new scientific paper outlining their findings.




This work from Owens and his team helps change that, offering unexpected insights into the caps’ composition and origins. Scientists have thought that the caps were derived almost exclusively from smooth muscle cells, but Owens’ findings reveal that there is a “tapestry” of different cell types involved. “For years we assumed that most of the protective fibrous cap cells were of smooth muscle cell origin because that’s what they look like under the microscope,” Newman said, adding, “Advanced techniques show us how dynamic this structure really is.”

Baylis noted that “having multiple cell types contribute to the fibrous cap likely make this critically important structure more robust and resistant to plaque rupture.”

Up to 40% of the fibrous cells in the cap in lab mice come from sources other than smooth muscle cells, the researchers found. In advanced human lesions, approximately 20% to 25% of the fibrous cap cells came from other sources. Those other sources include endothelial cells – cells that line our blood vessels – and immune cells called macrophages, typically viewed as being pro-inflammatory and plaque de-stabilizing, that have undergone special transitions that enable them to perform plaque-stabilizing functions.

The researchers went on to provide evidence that the formation of the fibrous cap is dependent on metabolic reprogramming of these cells to perform processes that are essential to plaque stabilization. The findings suggest that clinicians may one day be able to treat the underlying causes of heart attacks and strokes by enhancing these transitions through novel drug therapies and dietary modifications to help ensure patients have stable caps.

“Our studies unveil a potential new approach for reducing the probability of plaque rupture, which could be used in conjunction with current therapies that focus on lowering cholesterol and preventing clot formation,” Owens said.







Today's News

March 26, 2021

Potential COVID-19 treatment identified in UCLA-led lab study

Cambridge leads trial to see if tapeworm drug can boost protection from COVID-19 among vulnerable

New result from LHCb experiment challenges leading theory in physics

UVA discovery reveals potential way to prevent heart attacks, strokes

Three common antiviral drugs potentially effective against COVID-19

Excess blood sugar promotes clogging of arteries: study

Air pollution: The silent killer called PM2.5

Neil Ashcroft, world-renowned theoretical physicist, dies at 82

Nanoengineers develop self-repairing microbots

Gene changes linked to severe repetitive behaviors

US hails first signs of vaccine success even as cases plateau

Penn Medicine study illuminates the molecular details of lung development

Warming drives 'fundamental' changes to ocean, scientists warn

It's snowing plastic

Female salmon are dying at higher rates than male salmon

Bald eagle count quadruples, thanks in part to eBird data boost



 


Editor & Publisher: Jose Villarreal
Art Director: Juan José Sepúlveda Ramírez



Tell a Friend
Dear User, please complete the form below in order to recommend the ResearchNews newsletter to someone you know.
Please complete all fields marked *.
Sending Mail
Sending Successful